News | March 22, 2023
PHARMAP 2023 to focus on pharmaceutical challenges and strategies
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
The British-Swedish pharma major certainly has a strong competitive edge for BTC treatment in the country
Merck and Ridgeback will appeal the decision and request a re-examination of the CHMP’s opinion.
A pharma industry veteran with over three decades of experience in domestic as well as international markets
Approval marks fifth indication for KEYTRUDA-based regimens in NSCLC and 34th indication for KEYTRUDA in the US
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
40,000 visitors and representatives of more than 80 countries set to visit the show
Subscribe To Our Newsletter & Stay Updated
